“You might carry the gene (or trait) for sickle cell disorder and not even know it,” says Virginia Tshibangu, a Clinical ...
Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have ...
GlobalData on MSN3d
IGC adds new clinical site in Canada for Alzheimer’s agitation therapy trialIGC Pharma has added Hamilton Health Sciences (HHS) in Canada as a new clinical site for its ongoing, randomised Phase II ...
Scientists have found a potential new gene variant target to treat sickle cell disease, an inherited blood disorder that ...
Watching no more than one hour of TV a day may lower the risk of heart attack, stroke and other blood vessel diseases among ...
PTC Therapeutics, Inc. (NASDAQ: PTCT) today shared new data being presented from the Phase 3 APHENITY trial and subsequent open-label extension study at the 2025 American College of Medical Genetics ...
In an update yesterday on scientific investigations related to H5N1 avian flu activity, the Centers for Disease Control and ...
A medical epidemiologist explains who should consider getting a booster and whether you might need to check your antibody ...
PTC Therapeutics (PTCT) shared new data being presented from the Phase 3 APHENITY trial and subsequent open-label extension study at the 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback